Economic evaluation of docetaxel for breast cancer

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.10, Iss.2, 2009-02, pp. : 283-290

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Economic Evaluation of Docetaxel and Paclitaxel Regimens in Metastatic Breast Cancer in the UK

By Benedict Ágnes

PharmacoEconomics, Vol. 27, Iss. 10, 2009-10 ,pp. : 847-859

Adis International

Access to resources Recommend Favorite

Paclitaxel and docetaxel in the treatment of breast cancer

By Saloustros Emmanouel Mavroudis Dimitris Georgoulias Vassilis

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 15, 2008-10 ,pp. : 2603-2616

Informa Healthcare

Access to resources Recommend Favorite

Docetaxel: a workhorse in breast cancer therapy

Inpharma, Vol. 1, Iss. 1273, 2001-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Docetaxel regimen improves survival in early breast cancer

Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Docetaxel response, toxicity related to dose in breast cancer

Inpharma, Vol. 1, Iss. 1562, 2006-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite